|
|
Program outline
Thursday | Friday | Saturday | Sunday
2016 CRS meeting learning objectives
At the end of this meeting, participants will be able to:
- Describe present and future uses of optical coherence tomography
- Identify the technological and technique-based advances in Vitreoretinal surgery
- Describe the imaging features and therapeutic options for macular disease(s)
- Identify the evolving trends and practices of Canadian Retina Specialists in the management of retinal disease(s)
| Thursday, March 3 2016 |
| 1200-1500 | Arrivals |
| 1620-1725 | Scientific session 1 - Medical Retina Case Conference
At the end of this session, participants will be able to:
- Expand their differential diagnosis for medical retinal conditions
- Identify uncommon retinal diseases
- Enhance their management of retinal diseases
| 1620 | Welcome · Jim Whelan, MD and Netan Choudhry, MD |
| 1625 | Mystery cases · Panelists: Deepa Yoganathan, MD (moderator), K. Bailey Freund, MD, Netan Choudhry, MD, Jim Whelan, MD
- Mystery Case 1: Amelanotic choroidal mass · Alice Yang Zhang
- Mystery Case 2: Black spot in the left eye · Alice Yang Zhang
- Mystery Case 3: Dark knight disease? · Rishi Gupta
- Mystery Case 4: Inner and outer retinal changes in a case of Alport syndrome · Rayan Alshareef
- Mystery Case 5: Simultaneous central retinal artery occlusion and optic Nerve Vasculitis in Crohn's Disease · Razek Georges Coussa
- Mystery Case 6: On wide field F/A and anti-VEGF · Marie Carole Boucher
- Mystery Case 7: Is it AMD? · Errol Chan
- Mystery Case 8: A progressive pigmentary retinopathy · David Maberley
|
| 1725 | Adjourn |
|
| 1730-1900 | CRS Annual General Meeting |
| 1900-2000 | Welcome reception |
| Friday, March 4, 2016 |
| 0600-0630 | Breakfast |
| 0630-0855 | Scientific session 2 - Retinal Imaging I
At the end of this session, participants will be able to:
- Identify recent changes to our understanding of OCT-based retinal anatomy
- Indicate key imaging features of age-related macular degeneration subtypes
- Become familiar with newer microbes implicated in culture-negative endophthalmitis
| 0630 | Welcome and introductions · Netan Choudhry, MD |
| 0635 | Evolving understanding of ocular anatomy and disease with OCT · Alex Walsh, MD |
| 0655 | Q & A |
| 0705 | Imaging neovascular subtypes in AMD · K. Bailey Freund, MD |
| 0725 | Q & A |
| 0735 | What intravitreal injections have taught us about endophthalmitis/First person recording of retinal procedures · Sunir Garg, MD |
| 0755 | Panel discussion · Netan Choudhry, MD (moderator), Sunir Garg, MD, Alex Walsh, MD, K. Bailey Freund, MD |
| 0805 | Anti-VEGF switch and adverse event cases (includes Q & A) · Panelists: Deepa Yoganathan, MD (moderator), K. Bailey Freund, MD, Rishi Gupta, MD
- Anti-VEGF Switch Case 1: A tale of two switches · Nilesh Persad
- Anti-VEGF Switch Case 2: Switching from ranibizumab to aflibercept showed early remarkable visual and morphologic outcome in a case with wet age-related macular degeneration · Aissa Iggui
- Adverse Event Case 1: Infectious necrotizing scleritis after intravitreal ranibizumab injection · Razek Georges Coussa
- Adverse Event Case 2: Is there a relationship between anti-VEGF therapy and cranial nerve palsy? · Nilesh Persad
- Adverse Event Case 3: Where did that hole come from? · Deepa Yoganathan
|
| 0855 | Adjourn |
|
| 0855-0910 | Refreshment break |
| 0910-1010 | Co-developed symposium: wARMD 360° - Evolution of Disease Management
SEE POSTER
Planning Committee: Chair/CRS representative: Netan Choudhry, MD, Members: Rishi Gupta, MD, David E. Lederer, MD
Faculty: Netan Choudhry, MD, Joan W. Miller, MD, Rishi Gupta, MD, K. Bailey Freund, MD, David E. Lederer, MD
At the end of this session, participants will be able to:
- Describe the evolution of treatments for exudative ARMD
- Discuss the current evidence for switching agents in the treatment of wet ARMD and non-responders
- Assess the evidence regarding a possible association between intravitreal anti-VEGF therapy and macular atrophy in neovascular ARMD
- Identify the evolving role of OCT-angiography in the management of neovascular ARMD
| 0910 | Welcome and introductions · Netan Choudhry, MD |
| 0915 | A brief history of the management of neovascular ARMD · Rishi Gupta, MD |
| 0925 | Switching agents: when, how, why? · Joan W. Miller, MD |
| 0935 | Geographic atrophy in the anti-VEGF era · K. Bailey Freund, MD |
| 0945 | New frontiers in retinal imaging: OCT-angiography for wet ARMD · Netan Choudhry, MD |
| 0955 | Panel discussion · Moderators: Netan Choudhry, MD, David E. Lederer, MD
Faculty: K. Bailey Freund, MD, Rishi Gupta, MD, Joan W. Miller, MD |
This session was co-developed by the Canadian Retina Society, the Canadian Ophthalmological Society and Bayer and was planned to achieve scientific integrity, objectivity and balance
|
| 1010 | Adjourn |
| 1530-1600 | Refreshment break |
| 1600-1830 | Scientific session 3 - Retinal Imaging II
At the end of this session, participants will be able to:
- Discuss future developments in optical coherence tomography
- Describe the current research in retinal anatomy using optical coherence tomography
- Assess the role of the choroid within the pachychoroid spectrum
- Identify imaging features of White Dot Syndromes
| 1600 | Introduction · Jim Whelan, MD |
| 1605 | New frontiers in OCT · Alex Walsh, MD |
| 1625 | Q & A |
| 1635 | New multi-modal imaging findings in white dot syndromes · K. Bailey Freund, MD |
| 1655 | Q & A |
| 1705 | Automated multi-functional OCT · Alex Walsh, MD |
| 1725 | Q & A |
| 1735 | The pachychoroid spectrum - K. Bailey Freund, MD |
| 1800 | Panel discussion · Jim Whelan, MD (moderator), Alex Walsh, MD, K. Bailey Freund, MD, David Maberley, MD |
| 1830 | Adjourn |
|
| 1900-2200 | A Night at the Sugar Shack, Reception-style dinner (off site) |
| Saturday, March 5, 2016 |
| 0600-0630 | Breakfast |
| 0630-0855 | Scientific session 4 - Vitreoretinal Surgery
At the end of this session, participants will be able to:
- Discuss the challenges in retinal detachment surgery & role of ILM peeling
- Demonstrate the utility of 27-gauge vitrectomy in vitreoretinal surgery
- Describe the real-world utility of ocriplasmin in symptomatic vitreomacular adhesion (sVMA)
- Identify novel methods of IOL rescue and secondary IOL placement
| 0630 | Welcome and introductions · Jim Whelan, MD |
| 0635 | Retinal detachment: a primer · Gaurav Shah, MD |
| 0700 | Q & A |
| 0710 | 27-gauge surgery: applications and limitations · Gaurav Shah, MD |
| 0735 | Q & A |
| 0745 | Clinical reality of ocriplasmin use and outcomes · Gaurav Shah, MD |
| 0810 | Q & A |
| 0820 | Secondary intraocular lenses · Sunir Garg, MD |
| 0845 | Panel discussion · Jim Whelan, MD (moderator), Gaurav Shah, MD, Sunir Garg, MD, Flavio Rezende, MD |
| 0855 | Adjourn |
|
| 0855-0910 | Refreshment break |
| 0910-1010 | Co-developed symposium - Advanced VR Course: Do you know your vitrectomy machine? Things you want to know.
SEE POSTER
Planning Committee: Chair: Wai-Ching Lam, MD, CRS Representative: Jim Whelan, MD, Member: Michael Kapusta, MD
Faculty: Wai-Ching Lam, MD, Jim Whelan, MD, Michael Kapusta, MD, David Chow, MD, Hugh Parsons, MD
At the end of this session, participants will be able to:
- Describe principles and physiological rational of the various vitrectomy parameters
- Identify the advanced settings of the vitrectomy machine
- Apply the new knowledge of the vitrectomy to achieve better patient surgical outcome
| 0910 | Welcome and introductions · Wai-Ching Lam, MD |
| 0915 | VGFI, flow limit, IOP control.... Do you know what all this means? · Michael Kapusta, MD |
| 0925 | Advanced settings of the vitrectomy machine: it’s time to find out what they are · David Chow, MD |
| 0935 | The development of vitreo-retinal surgery – past, present and future · Hugh Parsons, MD |
| 0945 | Panel discussion · Moderator: Wai-Ching Lam, MD
Faculty: David Chow, MD, Michael Kapusta, MD, Hugh Parsons, MD |
This session was co-developed by the Canadian Retina Society, the Canadian Ophthalmological Society, and Alcon to achieve scientific integrity, objectivity, and balance.
|
| 1010 | Adjourn |
| 1530-1600 | Refreshment break |
| 1600-1745 | Scientific session 5 - Vision Rehabilitation & Therapeutics
At the end of this session, participants will be able to:
- Determine the retina specialist's role in vision rehabilitation
- Identify emerging therapies for dry age-related macular degeneration
| 1600 | Introductions · Netan Choudhry, MD, with remarks by John Galic, MD, President of the Retina Foundation of Canada |
| 1605 | Dr. Mila Oh Memorial Lecture: Vision rehabilitation for the patient receiving intravitreal injections · Mary Lou Jackson, MD
|
| 1650 | Q & A |
| 1700 | Emerging therapies for dry AMD · Sunir Garg, MD |
| 1720 | Panel discussion · Jim Whelan, MD (moderator), Sunir Garg, MD |
| 1735 | Foundation Fighting Blindness · Remarks by Dr. Mary Sunderland, Director of Research & Education |
| 1745 | Adjourn |
|
| 1900-2000 | Ice Bar Reception |
| Sunday, March 6, 2016 |
| 0630-0700 | Breakfast |
| 0700-1000 | Scientific session 6 - Canadian Retina Practice Perspectives
At the end of this session, participants will be able to:
- Identify the trends in Anti-VEGF management of retinal disease in Canada
- Describe the surgical preferences and practices of Canadian vitreoretinal surgeons
- Discuss the socioeconomic variability in retinal practices and coverage across Canada
| 0700 |
Introduction · Jim Whelan, MD |
| 0705 | Expanding the dialogue: results of the Canadian Preferences and Trends (CAN-PAT) Survey · Netan Choudhry, MD, Jim Whelan, MD |
| 0735 | Q & A |
| 0805 | Challenging surgical cases · Panelists: Deepa Yoganathan, MD (moderator), Michael Kapusta, MD, Amin Kherani, MD
- Surgical Case 1: The use of the pericardial patch in retinal surgery · Hugh Parsons
- Surgical Case 2: Clinical presentation, management and outcome of two perforating globe injuries · Amin Kherani
- Surgical Case 3: Subretinal perfluorocarbon liquid · Alice Yang Zhang
- Surgical Case 4: A web of mystery · Cynthia Qian
- Surgical Case 5: The unrelenting detachment · Mikel Mikhail
- Surgical Case 6: Triamcinolone acetonide used to prevent IFCG toxicity during an inverted flap chromo surgery for large FTMH · Aissa Iggui
- Surgical Case 7: Extreme post-op complication · Peng Yan
- Surgical Case 8: Management of giant retinal tear detachment · Michael Dollin
- Surgical Case 9: Working toward a cell-based therapy for geographic atrophy · Peter Kertes
- Mystery Case 9: The clue was in the past medical history · Julie Vadboncoeur
- Mystery Case 10: Postoperative hemorrhagic occlusive retinal vasculitis · Ananda Kalevar
- Mystery Case 11: Pigmentary retinal degeneration · Marina Gilca
|
| 1000 | Adjourn |
|
|
